Target intelligence / Profile preview

Tubulin beta-4A chain mRNA (TUBB4A mRNA) (TUBB4A mRNA)

Target
TUBB4A mRNA
Molecular classification
Messenger RNA, Tubulin family, Cytoskeletal protein transcript
01

Overview

TUBB4A mRNA is the transcript of the TUBB4A gene, which encodes the beta-4A tubulin subunit, a primary component of microtubules highly expressed in the central nervous system, particularly within oligodendrocytes (UniProt P04350). These microtubules are vital for maintaining cellular architecture, facilitating intracellular transport, and supporting the myelination process (PubMed: 23911918). Mutations in the TUBB4A gene, such as the common p.Asp249Asn variant, cause a spectrum of neurodegenerative leukodystrophies, most notably Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC), characterized by a toxic gain-of-function that disrupts microtubule dynamics (PubMed: 32037394). Because the disease is often driven by the presence of the mutant protein, the mRNA transcript has become a therapeutic target for antisense oligonucleotides (ASOs) like ION464 (also known as BIIB129). These ASOs are designed to bind to the TUBB4A mRNA and trigger its degradation via RNase H, thereby reducing the production of the toxic tubulin protein and potentially halting disease progression (Ionis Pharmaceuticals, 2023). By lowering the levels of the aberrant protein, the therapy aims to restore normal cellular function and halt the progression of neurodegeneration.

Other names
TUBB4 mRNATubulin beta-4 chain mRNATbeta4 mRNABeta-4 tubulin mRNATUBB4A transcript
02

Mechanism of action

Antisense oligonucleotide-mediated degradation of mRNA via RNase H1 recruitment to reduce toxic protein expression.

03

Biological functions

Microtubule assemblyCytoskeleton organizationIntracellular transportOligodendrocyte differentiationMyelination
04

Disease associations

Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC)Dystonia 4 (DYT4)LeukodystrophyNeurodegenerative disease
05

Safety considerations

Off-target mRNA degradationCNS inflammatory responsePotential for excessive knockdown of essential tubulinDelivery challenges across the blood-brain barrier
06

Interacting drugs

ION464

1 more in the full profile.

07

Biomarkers

TUBB4A mRNA levelsNeurofilament light chain (NfL)MRI-based myelin quantification

Beyond the preview

Go deeper on Tubulin beta-4A chain mRNA (TUBB4A mRNA) (TUBB4A mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin beta-4A chain mRNA (TUBB4A mRNA) (TUBB4A mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call